Author

Yusra Azzam

Observed name: Azzam, Yusra

Institution: University at Buffalo, State University of New York

Observed institution: University at Buffalo, State University of New York

ORCID: 0009-0009-3562-6963

Observed ORCID: 0009-0009-3562-6963

OpenAlex ID: A5116907325

Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery

2025 · Rand Shahin, Sawsan Jaafreh, et al. · Future Science OA · 26

A comprehensive in-silico approach (pharmacophoric QSAR and docking-based comparative intermolecular analysis) led to identifying new PIM2 kinase inhibitors for treating resistant lymphomas

2025 · Rand Shahin, Sawsan Jaafreh, et al. · Letters in Drug Design & Discovery · 5

Discovery of Novel Polycyclic Aromatic Inhibitors of Anaplastic Lymphoma Kinase (ALK) via Integrated QSAR Modeling, Machine Learning, and Pharmacophore-Guided Virtual Screening with AI-Assisted Mechanistic Interpretation of Structure–Activity Relationships

2026 · Rand Shahin, Hiba Zalloum, et al. · Research Square

Discovery of novel acridine based inhibitors of Bruton’s tyrosine kinase (BTK) via pharmacophore modeling and machine learning-driven virtual screening followed by molecular dynamic studies

2026 · Rand Shahin, Sawsan Jaafreh, et al. · Journal of Computer-Aided Molecular Design

Bridging the antiviral drug design gap: a combined machine learning and QSAR approach for drug repurposing of host kinase inhibitors

2026 · Rand Shahin, Yusra Azzam, et al. · Network Modeling Analysis in Health Informatics and Bioinformatics

Works count: 6

Citation count: 31

H-index: 2

I10-index: 1